Ron Strider
Well-Known Member
Two decades of state-by-state progression have resulted in legislation permitting the cannabis plant's access for patient use. Over that same time, industry has promoted assurances for legislation that enhance the cannabis plant's outcome.
More important than access to the plant or advancing for the plant's outcome, there is a critical need to advance and improve the patient's outcome as the single best measure of responsible health care.
All stakeholders benefit from proactively innovating legislation that improves the patient's outcome.
Until that happens, mainstream physicians will continue to reject being dictated their practice of medicine by non-medical legislators influenced by industry stakeholders.
Even though national estimates indicate nearly three million patients have accessed medical cannabis products, states have been short-sighted; unable to focus on a goal to improve patient outcome. Consistent with all other proactive health care initiatives, improving patient outcomes using cannabinoids can be achieved in several ways. Four 'common sense' innovations that are easy to legislate are:
- Require industry to undergo accreditation processes for Continuous Quality Improvement (CQI) as is used in all other health care entities. This supports best practices; and will ultimately lower risk;
- Require "Terpene" along with "Cannabinoid" analyses that fully informs authorizing doctors and patients about the benefits and risks of a unique plant strain. This is essential to good outcomes;
- Adopt the Federation of State Medical Board (FSMB) Practice Expectation Guidelines. This helps Boards of Medicine define a new health care science's acceptable physician practice standards;
- Empower a DOH expert committee to review petitions and efficiently add or remove diagnoses.
Without these essential mandates, physicians, Departments of Health, and Boards of Medicine will continue to encounter problems with facilitating a legitimate patient's access to "medical" marijuana.
When a legislator decides to undervalue health care's continuous quality improvement process, they will be federally challenged to explain how continued unfavorable patient outcomes were permitted to occur.
Facts of medicine & realities of law
By 2016, while marijuana remained federally illegal, 28 states had already legislated their citizen's access for its medical use. When compared with a black market's potentially adulterated products, in states where a legitimate patient's access to medical cannabis was in effect, significant improvements from a burgeoning industry quickly advanced cannabis to hybridize therapeutic plant strains; separate their bioactive chemicals into oils; and assure their plant product's quality.
Nevertheless, today's mainstream physician's reluctance to treat patients with cannabis derives from its 1970 designation as a Schedule 1 substance; defined as having no accepted medical use, and a high potential for abuse as determined by the Federal Drug Enforcement Agency.
In January 2017, the prestigious National Academies of Science, Engineering and Medicine published "The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research". Several evidence-based medical uses, as well as a relatively limited potential for abuse were cited.
Bioethics: Do the right thing; but first, 'Do no harm'
As community-trusted thought leaders, licensed physicians throughout the United States have sought ethical guidance to answer this core question:
"Should a physician offer compassionate access to cannabis while under its federal prohibition?"
Healers seek to morally justify their indisputably vital roles in patient care. Many doctors in Florida have become qualified to authorize their patient's access to medical marijuana. These physicians are ethically bound as healers to render compassionate patient care, and their mandated continuing medical education included my analysis of the following bioethical position statement:
"Seeking relief from the physical, psychological or spiritual symptoms of disease is an instinctual force of human nature, and may contribute to medicinal use.
"The treatment of intolerable symptoms is an honorable task that a society bestows upon its healers to provide humane relief."
Jeffrey S. Block, M.D., is an American Board-Certified anesthesiologist, a voluntary professor of anesthesiology at the University of Miami's Miller School of Medicine; and fellowship- trained in pain management and addiction medicine.
News Moderator: Ron Strider 420 MAGAZINE ®
Full Article: Commentary | South Florida Opinions - Sun Sentinel
Author: Jeffrey S. Block
Contact: About the Sun Sentinel - Sun Sentinel
Photo Credit: None Found
Website: Broward & Palm Beach News, Sports - Sun Sentinel
More important than access to the plant or advancing for the plant's outcome, there is a critical need to advance and improve the patient's outcome as the single best measure of responsible health care.
All stakeholders benefit from proactively innovating legislation that improves the patient's outcome.
Until that happens, mainstream physicians will continue to reject being dictated their practice of medicine by non-medical legislators influenced by industry stakeholders.
Even though national estimates indicate nearly three million patients have accessed medical cannabis products, states have been short-sighted; unable to focus on a goal to improve patient outcome. Consistent with all other proactive health care initiatives, improving patient outcomes using cannabinoids can be achieved in several ways. Four 'common sense' innovations that are easy to legislate are:
- Require industry to undergo accreditation processes for Continuous Quality Improvement (CQI) as is used in all other health care entities. This supports best practices; and will ultimately lower risk;
- Require "Terpene" along with "Cannabinoid" analyses that fully informs authorizing doctors and patients about the benefits and risks of a unique plant strain. This is essential to good outcomes;
- Adopt the Federation of State Medical Board (FSMB) Practice Expectation Guidelines. This helps Boards of Medicine define a new health care science's acceptable physician practice standards;
- Empower a DOH expert committee to review petitions and efficiently add or remove diagnoses.
Without these essential mandates, physicians, Departments of Health, and Boards of Medicine will continue to encounter problems with facilitating a legitimate patient's access to "medical" marijuana.
When a legislator decides to undervalue health care's continuous quality improvement process, they will be federally challenged to explain how continued unfavorable patient outcomes were permitted to occur.
Facts of medicine & realities of law
By 2016, while marijuana remained federally illegal, 28 states had already legislated their citizen's access for its medical use. When compared with a black market's potentially adulterated products, in states where a legitimate patient's access to medical cannabis was in effect, significant improvements from a burgeoning industry quickly advanced cannabis to hybridize therapeutic plant strains; separate their bioactive chemicals into oils; and assure their plant product's quality.
Nevertheless, today's mainstream physician's reluctance to treat patients with cannabis derives from its 1970 designation as a Schedule 1 substance; defined as having no accepted medical use, and a high potential for abuse as determined by the Federal Drug Enforcement Agency.
In January 2017, the prestigious National Academies of Science, Engineering and Medicine published "The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research". Several evidence-based medical uses, as well as a relatively limited potential for abuse were cited.
Bioethics: Do the right thing; but first, 'Do no harm'
As community-trusted thought leaders, licensed physicians throughout the United States have sought ethical guidance to answer this core question:
"Should a physician offer compassionate access to cannabis while under its federal prohibition?"
Healers seek to morally justify their indisputably vital roles in patient care. Many doctors in Florida have become qualified to authorize their patient's access to medical marijuana. These physicians are ethically bound as healers to render compassionate patient care, and their mandated continuing medical education included my analysis of the following bioethical position statement:
"Seeking relief from the physical, psychological or spiritual symptoms of disease is an instinctual force of human nature, and may contribute to medicinal use.
"The treatment of intolerable symptoms is an honorable task that a society bestows upon its healers to provide humane relief."
Jeffrey S. Block, M.D., is an American Board-Certified anesthesiologist, a voluntary professor of anesthesiology at the University of Miami's Miller School of Medicine; and fellowship- trained in pain management and addiction medicine.
News Moderator: Ron Strider 420 MAGAZINE ®
Full Article: Commentary | South Florida Opinions - Sun Sentinel
Author: Jeffrey S. Block
Contact: About the Sun Sentinel - Sun Sentinel
Photo Credit: None Found
Website: Broward & Palm Beach News, Sports - Sun Sentinel
